Is a complete BMGL research report available?

No complete published report is available for Basel Medical Group Ltd (BMGL) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Basel Medical Group Ltd (BMGL)

NASDAQ: BMGL · USD

$5.21

+0.10 (+2.0%)· Recorded snapshot

Market cap	8.2M
Revenue (ttm)	16.6M
Net income (ttm)	-578K
EPS (ttm)	-$0.60
Shares out	1.6M
Volume	172,519.772

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 16.6M
Net income (ttm): -578K
EPS (ttm): -$0.60
Market cap: 8.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	احتفاظ

Metric	Value
Amount currency	USD
CIK code	0002004489
Company name	Basel Medical Group Ltd
Country	Singapore
Country code	US
CUSIP number	G0864B111
Earnings date	2026-06-26
Earnings time	bmo
Employees	82
Employees change	50
Employees growth	156.25%
Enterprise value	$15.3M
Exchange	NASDAQ
Financial currency	SGD
Financial report date	2025-12-31
First seen	2026-05-09
Fiscal year end	June
Founded	2001
Industry	Medical Care Facilities
IPO date	2025-02-25
Is primary listing	Yes
Is SPAC	No
ISIN number	VGG0864B1114
Last 10-K release date	2026-10-30
Last earnings date	2026-06-26
Last refreshed	2026-11-04
Last stock split date	2026-06-22
Last stock split type	Reverse
Market cap	$8.2M
Market cap category	Nano-Cap
Next earnings date	2027-05-23
Options	No
Price	$5.21
Price currency	USD
Sector	Healthcare
SIC code	8011
Stock price date	2026-11-03
Symbol	BMGL
Website	https://baselmedical.com

Metric

Value

Amount currency

USD

CIK code

0002004489

Company name

Basel Medical Group Ltd

Country

Singapore

Country code

CUSIP number

G0864B111

Earnings date

2026-06-26

Earnings time

bmo

Employees

Employees change

Employees growth

156.25%

Enterprise value

$15.3M

Exchange

NASDAQ

Financial currency

SGD

Financial report date

2025-12-31

First seen

2026-05-09

Fiscal year end

June

Founded

2001

Industry

Medical Care Facilities

IPO date

2025-02-25

Is primary listing

Yes

Is SPAC

ISIN number

VGG0864B1114

Last 10-K release date

2026-10-30

Last earnings date

2026-06-26

Last refreshed

2026-11-04

Last stock split date

2026-06-22

Last stock split type

Reverse

Market cap

$8.2M

Market cap category

Nano-Cap

Next earnings date

2027-05-23

Options

Price

$5.21

Price currency

USD

Sector

Healthcare

SIC code

8011

Stock price date

2026-11-03

Symbol

BMGL

Website

https://baselmedical.com

Metric	Value
Earnings yield	-11.57%
EV/Sales	0.92x
FCF / EV yield	-4.53%
FCF yield	-8.38%
Industry forward P/E	15.46x
Industry P/E	17.9x
P/B ratio	2.13x
P/S ratio	0.5x
Price / tangible book value	2.11x
Sector forward P/E	23.32x
Sector P/E	49.47x

Metric

Value

Earnings yield

-11.57%

EV/Sales

0.92x

FCF / EV yield

-4.53%

FCF yield

-8.38%

Industry forward P/E

15.46x

Industry P/E

17.9x

P/B ratio

2.13x

P/S ratio

0.5x

Price / tangible book value

2.11x

Sector forward P/E

23.32x

Sector P/E

49.47x

Metric	Value
EBIT margin	-3.67%
EBITDA margin	-2.04%
Gross margin	38.77%
Operating margin	-3.67%
Pretax margin	-5.81%
Profit margin	-3.48%
Profit per employee	$-7,049
Revenue per employee	$202,728
ROA	-2.71%
ROCE	-9.97%
ROE	-28.66%
ROIC	-5.8%
ROIC (5Y)	1.13%
SBC / revenue	1.39%
Tax / revenue	0.83%

Metric

Value

EBIT margin

-3.67%

EBITDA margin

-2.04%

Gross margin

38.77%

Operating margin

-3.67%

Pretax margin

-5.81%

Profit margin

-3.48%

Profit per employee

$-7,049

Revenue per employee

$202,728

ROA

-2.71%

ROCE

-9.97%

ROE

-28.66%

ROIC

-5.8%

ROIC (5Y)

1.13%

SBC / revenue

1.39%

Tax / revenue

0.83%

Metric	Value
EPS growth years	0
Gross profit growth	246.84%
Gross profit growth (Q)	-67.84%
Gross profit growth 3Y	26.06%
Net income growth years	1
Revenue growth	89.46%
Revenue growth (Q)	67.08%
Revenue growth (QoQ)	33.38%
Revenue growth 3Y	30.2%
Revenue growth years	3

Metric

Value

EPS growth years

Gross profit growth

246.84%

Gross profit growth (Q)

-67.84%

Gross profit growth 3Y

26.06%

Net income growth years

Revenue growth

89.46%

Revenue growth (Q)

67.08%

Revenue growth (QoQ)

33.38%

Revenue growth 3Y

30.2%

Revenue growth years

Metric	Value
Capital expenditures	$-194,121
Depreciation and amortization	$274,229
EBIT	$-610,857
EBITDA	$-339,878
EPS	$-0.60
FCF per share	$-0.44
Financing cash flow	$-1.4M
Free cash flow	$-690,861
Free cash flow minus SBC	$-925,465
Gross profit	$6.4M
Income taxes	$138,755
Investing cash flow	$-80,552
Net borrowing	$-1.4M
Net cash flow	$-1.9M
Net income	$-578,008
Operating cash flow minus SBC	$-731,344
Operating income	$-610,857
Revenue	$16.6M
Stock-based compensation	$231,823

Metric

Value

Capital expenditures

$-194,121

Depreciation and amortization

$274,229

EBIT

$-610,857

EBITDA

$-339,878

EPS

$-0.60

FCF per share

$-0.44

Financing cash flow

$-1.4M

Free cash flow

$-690,861

Free cash flow minus SBC

$-925,465

Gross profit

$6.4M

Income taxes

$138,755

Investing cash flow

$-80,552

Net borrowing

$-1.4M

Net cash flow

$-1.9M

Net income

$-578,008

Operating cash flow minus SBC

$-731,344

Operating income

$-610,857

Revenue

$16.6M

Stock-based compensation

$231,823

Metric	Value
Book value per share	$2.44
Debt / EBITDA	3.1
Debt / equity	2.12
Interest coverage	-1.72
Long-term assets	$2.7M
Long-term liabilities	$4.4M
Net cash (debt)	$-7M
Net cash / market cap	-85.21%
Net debt / equity	2
Piotroski F-Score	3
Property, plant and equipment	$4.6M
Shareholders' equity	$3.5M
Tangible book value	$3.9M
Tangible book value per share	$2.44
Total assets	$13.7M
Total cash	$409,467
Total debt	$7.4M
Total liabilities	$10.2M

Metric

Value

Book value per share

$2.44

Debt / EBITDA

3.1

Debt / equity

2.12

Interest coverage

-1.72

Long-term assets

$2.7M

Long-term liabilities

$4.4M

Net cash (debt)

$-7M

Net cash / market cap

-85.21%

Net debt / equity

Piotroski F-Score

Property, plant and equipment

$4.6M

Shareholders' equity

$3.5M

Tangible book value

$3.9M

Tangible book value per share

$2.44

Total assets

$13.7M

Total cash

$409,467

Total debt

$7.4M

Total liabilities

$10.2M

Metric	Value
Asset turnover	1.18
Current assets	$11.1M
Current liabilities	$5.9M
Current ratio	1.23
Inventory turnover	36.59
Net working capital	$6.2M
Quick ratio	1.1
Working capital	$1.8M
Working capital turnover	2.13

Metric

Value

Asset turnover

1.18

Current assets

$11.1M

Current liabilities

$5.9M

Current ratio

1.23

Inventory turnover

36.59

Net working capital

$6.2M

Quick ratio

1.1

Working capital

$1.8M

Working capital turnover

2.13

Metric	Value
Buyback yield / dilution	-1.06%
Dividend yield	0%
Shareholder yield	-1.06%

Metric

Value

Buyback yield / dilution

-1.06%

Dividend yield

Shareholder yield

-1.06%

Metric	Value
150-day SMA	$6.04
1D price change	1.96%
1M price change	58.84%
1M total return	58.84%
1W price change	12.53%
1W total return	12.53%
1Y price change	-71.25%
1Y return CAGR	-71.27%
1Y total return	-71.25%
20-day SMA	$4.27
200-day SMA	$6.54
3M price change	-7.3%
3M total return	-7.3%
50-day SMA	$4.40
50-day SMA vs 200-day SMA	50under200
52-week high	$18.72
52-week high date	2025-11-04
52-week low	$2.56
52-week low date	2026-10-08
6M price change	-22.47%
6M total return	-22.47%
After-hours change	-2.11%
After-hours close	$5.21
After-hours price	$5.10
All-time high	$112.80
All-time high date	2025-06-02
All-time low	$2.56
All-time low date	2026-10-08
Average true range (ATR)	$0.36
Average volume	1.2M
Beta (1Y)	1.35
Beta (2Y)	0.4
Change from 52-week high	-72.17%
Change from 52-week low	103.52%
Change from all-time high	-95.38%
Change from all-time low	103.52%
Change from open	0.58%
Day's gap	1.37%
Dollar volume	$898,828
High price	$5.27
Low price	$5.13
Monthly RSI	32.9
Open price	$5.18
Position in 52-week range	57.14%
Premarket change	0.86%
Premarket close	$5.21
Premarket price	$5.26
Premarket volume	15.7K
Previous close	$5.11
Price vs 150-day SMA	-13.74%
Price vs 20-day SMA	22.1%
Price vs 200-day SMA	-20.37%
Price vs 50-day SMA	18.41%
Relative volume	0.15
Return from IPO open	-89.64%
Return from IPO price	30.25%
RSI	69.1
Sharpe ratio	-0.42
Sortino ratio	-0.61
Volume	172.5K
Weekly RSI	42.97
YTD price change	-11.39%
YTD total return	-11.39%

Metric

Value

150-day SMA

$6.04

1D price change

1.96%

1M price change

58.84%

1M total return

58.84%

1W price change

12.53%

1W total return

12.53%

1Y price change

-71.25%

1Y return CAGR

-71.27%

1Y total return

-71.25%

20-day SMA

$4.27

200-day SMA

$6.54

3M price change

-7.3%

3M total return

-7.3%

50-day SMA

$4.40

50-day SMA vs 200-day SMA

50under200

52-week high

$18.72

52-week high date

2025-11-04

52-week low

$2.56

52-week low date

2026-10-08

6M price change

-22.47%

6M total return

-22.47%

After-hours change

-2.11%

After-hours close

$5.21

After-hours price

$5.10

All-time high

$112.80

All-time high date

2025-06-02

All-time low

$2.56

All-time low date

2026-10-08

Average true range (ATR)

$0.36

Average volume

1.2M

Beta (1Y)

1.35

Beta (2Y)

0.4

Change from 52-week high

-72.17%

Change from 52-week low

103.52%

Change from all-time high

-95.38%

Change from all-time low

103.52%

Change from open

0.58%

Day's gap

1.37%

Dollar volume

$898,828

High price

$5.27

Low price

$5.13

Monthly RSI

32.9

Open price

$5.18

Position in 52-week range

57.14%

Premarket change

0.86%

Premarket close

$5.21

Premarket price

$5.26

Premarket volume

15.7K

Previous close

$5.11

Price vs 150-day SMA

-13.74%

Price vs 20-day SMA

22.1%

Price vs 200-day SMA

-20.37%

Price vs 50-day SMA

18.41%

Relative volume

0.15

Return from IPO open

-89.64%

Return from IPO price

30.25%

RSI

69.1

Sharpe ratio

-0.42

Sortino ratio

-0.61

Volume

172.5K

Weekly RSI

42.97

YTD price change

-11.39%

YTD total return

-11.39%

Metric	Value
Float	518K
Float percentage	32.74%
Shares change (QoQ)	-11.89%
Shares change (YoY)	1.06%
Shares held by insiders	13.5%
Shares held by institutions	0.07%
Shares outstanding	1.6M
Short % of float	2.5%
Short % of shares	0.82%
Short ratio	0.1 days

Metric

Value

Float

518K

Float percentage

32.74%

Shares change (QoQ)

-11.89%

Shares change (YoY)

1.06%

Shares held by insiders

13.5%

Shares held by institutions

0.07%

Shares outstanding

1.6M

Short % of float

2.5%

Short % of shares

0.82%

Short ratio

0.1 days

Basel Medical Group Ltd (BMGL)

Price

Financial snapshot

Fair-value bridge

Latest news · BMGL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BMGL indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BMGL

Frequently asked questions